These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16052981)

  • 1. [Electrogastrography monitoring of the effectiveness of prokinetic and cognitive therapy in functional dyspepsia].
    Fodor G; Schwab R; Gyökeres T; Pap A
    Orv Hetil; 2005 Jun; 146(26):1393-7. PubMed ID: 16052981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T; Barnert J; Dumitrascu DL; Fischer J; Wienbeck M
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia.
    Lim HC; Lee SI; Chen JD; Park H
    World J Gastroenterol; 2012 Nov; 18(41):5948-56. PubMed ID: 23139612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrogastrography in various clinical forms of functional dyspepsia].
    Foryś S; Rudnicki C; Walecka-Kapica E; Chojnacki J
    Pol Merkur Lekarski; 2009 May; 26(155):373-7. PubMed ID: 19606677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of electrogastrography for the diagnosis of gastroenterologic function].
    Pfaffenbach B; Adamek RJ; Lux G
    Dtsch Med Wochenschr; 1998 Jul; 123(28-29):855-60. PubMed ID: 9693655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia.
    Besherdas K; Leahy A; Mason I; Harbord M; Epstein O
    Aliment Pharmacol Ther; 1998 Aug; 12(8):755-9. PubMed ID: 9726389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia.
    Cutts TF; Abell TL; Karas JG; Kuns J
    Dig Dis Sci; 1996 Jul; 41(7):1369-78. PubMed ID: 8689913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric emptying and antral myoelectrical activity in chronic alcoholics with dyspepsia.
    Pfaffenbach B; Adamek RJ; Hagemann D; Schaffstein J; Wegener M
    Hepatogastroenterology; 1998; 45(22):1165-71. PubMed ID: 9756027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man.
    Pfaffenbach B; Adamek RJ; Hagelmann D; Schaffstein J; Wegener M
    Hepatogastroenterology; 1997; 44(17):1500-8. PubMed ID: 9356880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality.
    Chen JD; Ke MY; Lin XM; Wang Z; Zhang M
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1041-7. PubMed ID: 10930898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.
    Hveem K; Hausken T; Svebak S; Berstad A
    Scand J Gastroenterol; 1996 May; 31(5):452-7. PubMed ID: 8734341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
    Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
    J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical associations of functional dyspepsia with gastric dysrhythmia on electrogastrography: A comprehensive systematic review and meta-analysis.
    Varghese C; Carson DA; Bhat S; Hayes TCL; Gharibans AA; Andrews CN; O'Grady G
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14151. PubMed ID: 33830590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
    Holtmann G; Gschossmann J; Mayr P; Talley NJ
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1641-8. PubMed ID: 12197843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric myoelectrical activity in children and youth with dyspeptic symptoms].
    Szaflarska-Popławska A; Parzecka M; Zielińska I
    Pol Merkur Lekarski; 2006 Oct; 21(124):325-9. PubMed ID: 17205769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life.
    Abell TL; Cutts TF; Cooper T
    Scand J Gastroenterol Suppl; 1993; 195():60-3; discussion 63-4. PubMed ID: 8516661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal symptoms, electrogastrography, inflammatory markers, and PG-SGA in patients with advanced cancer.
    Chasen M; Bhargava R
    Support Care Cancer; 2012 Jun; 20(6):1283-90. PubMed ID: 21688162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observation on frequency spectrum of electrogastrogram (EGG) in acupuncture treatment of functional dyspepsia.
    Chen R; Kang M
    J Tradit Chin Med; 1998 Sep; 18(3):184-7. PubMed ID: 10453609
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia. Report of three cases.
    Cucchiara S; Minella R; Riezzo G; Vallone G; Vallone P; Castellone F; Auricchio S
    Dig Dis Sci; 1992 Jul; 37(7):1136-40. PubMed ID: 1618063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of cisapride on gastric tone and the perception of gastric distension.
    Tack J; Broeckaert D; Coulie B; Janssens J
    Aliment Pharmacol Ther; 1998 Aug; 12(8):761-6. PubMed ID: 9726390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.